TotalMarketCap

Rein Therapeutics

RNTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$53.589 M

$0.62 -5.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Rein Therapeutics (RNTX) has a market capitalization of $53.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$49.9M

Loss-making

Shares outstanding

86,267,032

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #329Corbus PharmaceuticalsCRBP$54.8M
  2. #330RenovoRxRNXT$53.9M
  3. #331Rein TherapeuticsRNTX$53.6M
  4. #332Verrica PharmaceuticalsVRCA$53.4M
  5. #333Heron TherapeuticsHRTX$52.8M

What if Rein Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$327,319.41

Per share 526,915× higher

Bitcoin $1.53T

$17,710.68

Per share 28,510× higher

Apple $5.02T

$58,142.52

Per share 93,597× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Rein Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.